DKK1 Human Pre-designed siRNA Set A contains three designed siRNAs for DKK1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DKK2 Human Pre-designed siRNA Set A contains three designed siRNAs for DKK2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DKK3 Human Pre-designed siRNA Set A contains three designed siRNAs for DKK3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DKK4 Human Pre-designed siRNA Set A contains three designed siRNAs for DKK4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DKKL1 Human Pre-designed siRNA Set A contains three designed siRNAs for DKKL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DL-2-Methylbutyric acid-13C2 is 13C labeled 1-(Pyridin-2-yl)ethan-1-one.

DL-Cysteine-d1 is the deuterated labeled 2-Amino-3-mercaptopropanoic acid (HY-W012850). 2-Amino-3-mercaptopropanoic acid is a cysteine derivative[1][2].

DL-Menthone-d8 is deuterated labeled Fructose-glutamic acid.

DL-Serine-15N is 15N-labeled DL-Serine (HY-Y0507) DL-Serine, a fundamental metabolite, is a mixture of D-Serine and L-Serine. DL-Serine has antiviral activity against the multiplication of tobacco mosaic virus (TMV).

DL-Sulforaphane N-acetyl-L-cysteine (SFN-NAC) is an orally active HDAC inhibitor and metabolite of sulforaphane (HY-13755) with longer half-life and better blood-brain barrier permeability. DL-Sulforaphane N-acetyl-L-cysteine activates autophagy-mediated downregulation of α-tubulin expression through the ERK pathway and can be used in cancer research[1][2].

DL-Sulforaphane N-acetyl-L-cysteine (SFN-NAC) is an orally active HDAC inhibitor and metabolite of sulforaphane (HY-13755) with longer half-life and better blood-brain barrier permeability. DL-Sulforaphane N-acetyl-L-cysteine activates autophagy-mediated downregulation of α-tubulin expression through the ERK pathway and can be used in cancer research[1][2].

DL-Tartaric acid (Standard) is the analytical standard of DL-Tartaric acid. This product is intended for research and analytical applications. DL-Tartaric acid is a non-racemic mixture of L- and D-tartaric acids with antioxidant activities[1][2].

DL-threo-PDMP hydrochloride is the hydrochloride form of DL-threo-PDMP that is a competitive glucosylceramide synthase (GCS) inhibitor. DL-threo-PDMP resensitizes refractory testicular germ cell tumors and epithelial ovarian cancer orthoxenografts to cisplatin in mice[1].

DLAT Human Pre-designed siRNA Set A contains three designed siRNAs for DLAT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DLC1 Human Pre-designed siRNA Set A contains three designed siRNAs for DLC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DLD Human Pre-designed siRNA Set A contains three designed siRNAs for DLD gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DLEC1 Human Pre-designed siRNA Set A contains three designed siRNAs for DLEC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DLG1 Human Pre-designed siRNA Set A contains three designed siRNAs for DLG1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DLG2 Human Pre-designed siRNA Set A contains three designed siRNAs for DLG2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DLG3 Human Pre-designed siRNA Set A contains three designed siRNAs for DLG3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DLG4 Human Pre-designed siRNA Set A contains three designed siRNAs for DLG4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DLG5 Human Pre-designed siRNA Set A contains three designed siRNAs for DLG5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DLGAP1 Human Pre-designed siRNA Set A contains three designed siRNAs for DLGAP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DLGAP2 Human Pre-designed siRNA Set A contains three designed siRNAs for DLGAP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DLGAP3 Human Pre-designed siRNA Set A contains three designed siRNAs for DLGAP3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DLGAP4 Human Pre-designed siRNA Set A contains three designed siRNAs for DLGAP4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DLGAP5 Human Pre-designed siRNA Set A contains three designed siRNAs for DLGAP5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DLK1 Human Pre-designed siRNA Set A contains three designed siRNAs for DLK1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DLK2 Human Pre-designed siRNA Set A contains three designed siRNAs for DLK2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DLL1 Human Pre-designed siRNA Set A contains three designed siRNAs for DLL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DLL3 Human Pre-designed siRNA Set A contains three designed siRNAs for DLL3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DLL4 Human Pre-designed siRNA Set A contains three designed siRNAs for DLL4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DLST Human Pre-designed siRNA Set A contains three designed siRNAs for DLST gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DLX1 Human Pre-designed siRNA Set A contains three designed siRNAs for DLX1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DLX2 Human Pre-designed siRNA Set A contains three designed siRNAs for DLX2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DLX3 Human Pre-designed siRNA Set A contains three designed siRNAs for DLX3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DLX4 Human Pre-designed siRNA Set A contains three designed siRNAs for DLX4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DLX5 Human Pre-designed siRNA Set A contains three designed siRNAs for DLX5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DLX6 Human Pre-designed siRNA Set A contains three designed siRNAs for DLX6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DM-PIT-1 is a PIP3/PH (phosphatidylinositol-3,4,5-triphosphate/Pleckstrin) interaction inhibitor[1]. DM-PIT-1 has the potential for the research of ovarian cancer[1].

Ravtansine (DM4) is a maytansinoid, a chemical derivative of maytansine being investigated as the cytotoxic payload of a number of antibody-drug conjugates (ADCs). Microtubules are dynamic cytoskeletal polymers that switch stochastically between states of growing and shortening, called “dynamic instability”. They function in the precise segregation of chromosomes during cell division, transport of cellular cargos, […]

DMAB-anabaseine dihydrochloride, an anabaseine compound, is a selective partial agonist for α7 nicotinic receptor[1].

DMABA NHS ester can chemically react with the primary amine groups of the major phospholipid component of the cell membrane, Phosphatidylethanolamine (PE). Through precursor ion scanning, all PE subclasses labeled with DMABA can be detected. DMABA NHS ester can be used in combination with isotope-labeled compounds such as DMABA-d6 NHS ester, DMABA-d10 NHS ester, and […]

DMAC1 Human Pre-designed siRNA Set A contains three designed siRNAs for DMAC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.